Clinical Trial Detail

NCT ID NCT02013336
Title Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors South Plains Oncology Consortium
Indications

Ewing sarcoma

neuroblastoma

rhabdomyosarcoma

osteosarcoma

Therapies

Cyclophosphamide + MM-398

Age Groups: child adult

No variant requirements are available.